Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment
Kosloski, Matthew P., Wang, Haoyu, Pugatch, David, Mensa, Federico J., Gane, Edward, Lawitz, Eric, Marbury, Thomas C., Preston, Richard A., Kort, Jens, Liu, WeiLanguage:
english
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-018-2576-4
Date:
October, 2018
File:
PDF, 608 KB
english, 2018